Business
Top brokers name 3 ASX shares to buy next week 17 January 2021
Last week saw a number of broker notes hitting the wires once again. Three buy ratings that caught my eye are summarised below.
Here’s why brokers think investors ought to buy them next week:
According to a note out of Credit Suisse, its analysts have retained their outperform rating and $4.30 price target on this healthcare company’s shares. The broker believes that Healius is well-placed to benefit from increased demand for COVID testing. Combined with a reduction in costs and smart investments, it is expecting strong earnings growth in the near term. The Healius share price ended the week at $3.88.
Analysts at Morgan Stanley have initiated coverage on this investigative analytics and intelligence software provider’s…
-
Noosa News17 hours agoFrom pigeons and Morse code to satellites and cyberspace: 100 years of the Royal Australian Corps of Signals
-
General21 hours agoIndia launches manhunt for those responsible for deadly attack in India-controlled Kashmir
-
General9 hours agoSleep study patients’ personal data accessed in ransomware attack, SA Health says
-
General20 hours agoTrump says peace deal between Russia and Ukraine ‘very close’ as he attacks Zelenskyy